354 related articles for article (PubMed ID: 22895613)
1. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD
Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613
[TBL] [Abstract][Full Text] [Related]
2. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation.
McGillicuddy JW; Taber DJ; Pilch NA; Kohout RK; Bratton CF; Chavin KD; Baliga PK
Prog Transplant; 2013 Mar; 23(1):33-8. PubMed ID: 23448818
[TBL] [Abstract][Full Text] [Related]
4. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
Tsapepas DS; Mohan S; Tanriover B; Dube G; Crew RJ; Cohen DJ; Hardy MA; Sandoval PR; Ratner LE
Transplantation; 2012 Aug; 94(4):325-30. PubMed ID: 22814328
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
[TBL] [Abstract][Full Text] [Related]
6. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
Klem P; Cooper JE; Weiss AS; Gralla J; Owen P; Chan L; Wiseman AC
Transplantation; 2009 Oct; 88(7):891-6. PubMed ID: 19935460
[TBL] [Abstract][Full Text] [Related]
7. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
Esposito L; Kamar N; Durand D; Rostaing L
Transplant Proc; 2005 Mar; 37(2):892-4. PubMed ID: 15848567
[TBL] [Abstract][Full Text] [Related]
8. Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients.
Varga AN; Johnson D; Sawinski DL; Lim MA; Bloom RD; Abt PL; Goral S; Bleicher M; Levine MH; Naji A; Nazarian S; Porrett P; Trofe-Clark J
Pharmacotherapy; 2018 Jun; 38(6):620-627. PubMed ID: 29665038
[TBL] [Abstract][Full Text] [Related]
9. Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients.
Marvin MR; Droogan C; Sawinski D; Cohen DJ; Hardy MA
Transplantation; 2003 Feb; 75(4):488-9. PubMed ID: 12605115
[TBL] [Abstract][Full Text] [Related]
10. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
Patel SJ; Knight RJ; Suki WN; Abdellatif A; Duhart BT; Krauss AG; Mannan S; Nezakatgoo N; Osama Gaber A
Clin Transplant; 2011; 25(3):E250-6. PubMed ID: 21231963
[TBL] [Abstract][Full Text] [Related]
11. Effects of Ideal Versus Total Body Weight Dosage of Rabbit Antithymocyte Globulin on Outcomes of Kidney Transplant Patients With High Immunologic Risk.
Vacha M; Gommer J; Rege A; Sanoff S; Sudan D; Harris M
Exp Clin Transplant; 2016 Oct; 14(5):511-517. PubMed ID: 26742693
[TBL] [Abstract][Full Text] [Related]
12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience.
Yang JW; Wang JN; Men TY; Zhang XM; Li XD; Shen B; Li GY; Chen DD
Ann Transplant; 2014 Jun; 19():277-82. PubMed ID: 24906405
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
[TBL] [Abstract][Full Text] [Related]
15. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.
Stevens RB; Foster KW; Miles CD; Lane JT; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Nielsen KJ; Skorupa JY; Kellogg AM; Malik T; Wrenshall LE
Transplantation; 2015 Jan; 99(1):197-209. PubMed ID: 25083614
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.
Rogers CC; Asipenko N; Horwedel T; Gautam S; Goldfarb-Rumyantzev AS; Pavlakis M; Johnson SR; Karp SJ; Evenson A; Khwaja K; Hanto DW; Mandelbrot DA
Am J Nephrol; 2013; 38(5):397-404. PubMed ID: 24192457
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
[TBL] [Abstract][Full Text] [Related]
19. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
Laftavi MR; Patel S; Soliman MR; Alnimri M; Kohli R; Said M; Pankewycz O
Transplant Proc; 2011 Mar; 43(2):466-8. PubMed ID: 21440735
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
Pilch NA; Taber DJ; Moussa O; Thomas B; Denmark S; Meadows HB; McGillicuddy JW; Srinivas TR; Baliga PK; Chavin KD
Ann Surg; 2014 May; 259(5):888-93. PubMed ID: 24513787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
